Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Immunicum | CEO interview, Erik Manting, CEO, Immunicum
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Immunicum | CEO interview, Erik Manting, CEO, Immunicum
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Casella Waste Systems' company culture is evaluated during "20 Leadership Lessons" with ZipRecruiter Co-Founder and CEO Ian Siegel.
00:10:00
Paul Henrietti Reflects on Sanlam's Challenges and Future Amidst Global Turbulence | Paul Hanratty, CEO, Sanlam.
00:10:00
Yukon Project Generator: Diverse Opportunities with Strong Risk-Reward Potential
00:10:00
4GLOBAL PLC CEO Eloy Mazon Discusses Strong Year and Future Focus | Eloy Mazon, CEO, 4GLOBAL PLC.
00:10:00
Financial Consultant Overview: Elliott Financial Group and StraitGate Financial, LLC.
00:10:00
OWAI with Michael Huttman, Founder and Chairman of Millennium Global | Michael Huttman - Founder and Chairman of Millennium Global
00:10:00
In a discussion with Nick Bolton, CEO of Oxford Metrics Plc, hosted by Oli Barrett MBE, marking the third consecutive year of the event.
00:10:00
Fed Chair Powell Urges Patience Amid Economic Uncertainty, Highlights Risks from Tariffs and Public Sentiment on Inflation|Jerome Powell,Chair,Federal Reserve
00:00:00
Cipher Pharmaceuticals (TSX: CPH) Update with Craig Mull - CEO, Cipher Pharmaceuticals Inc
00:10:00
Learn about the top trends and technologies in psychedelic therapeutics|Amy Kruse,General Partner,Prime Movers Lab
00:10:00
His hub and spoke strategy in Quebec, recent drilling results, and drill targets for 2023|ERNEST MAST,CEO,Dore Copper Mining
00:10:00
JSA Insights – Market Moves in the 2nd Quarter of 2021 | Jason Schmitt - Co-Founder and Managing Partner at Jacobson & Schmitt Advisors